The University of Montreal Hospital Research Centre

National knowledge translation planning and community and clinician-led initiatives for the release of low-risk cannabis use guidelines for youth with psychosis including findings from a mobile health study evaluating the effectiveness of behavior change interventions for reducing cannabis use for youth with psychosis.

Protocol development for two clinical trials for cannabis use: 1) Cannabinoid replacement for adults with psychosis and cannabis use disorder. 2) Modulation of THC’s effects by cannabidiol (CBD) at different THC/CBD 1:1 ratio doses in occasional users.

Project management of two multi-centre trials that are piloting mobile health interventions for youth who have been diagnosed with early episode psychosis and use cannabis.

Qualitative interviews with clinicians, support workers and youth on experiences with a new mobile app technology to reduce cannabis use.